BFLY Quote, Financials, Valuation and Earnings

Intelligent Bio Solutions has a net margin of -80.99% compared to Butterfly Network's net margin of -370.29%. Butterfly Network's return on equity of -37.41% beat Intelligent Bio Solutions's return on equity of -164.63%.

Butterfly Network has a consensus price target of $5.00, signalling upside risk potential of 86.57%. On the other hand Intelligent Bio Solutions has an analysts' consensus of -- which suggests that it could grow by 458.14%. Given that Intelligent Bio Solutions has higher upside potential than Butterfly Network, analysts believe Intelligent Bio Solutions is more attractive than Butterfly Network.

Butterfly Network has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Intelligent Bio Solutions has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Butterfly Network has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Butterfly Network pays -- of its earnings as a dividend. Intelligent Bio Solutions pays out -- of its earnings as a dividend.

Butterfly Network quarterly revenues are $22.4M, which are larger than Intelligent Bio Solutions quarterly revenues of $607.5K. Butterfly Network's net income of -$18.1M is lower than Intelligent Bio Solutions's net income of -$2.2M. Notably, Butterfly Network's price-to-earnings ratio is -- while Intelligent Bio Solutions's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Butterfly Network is 6.91x versus 2.46x for Intelligent Bio Solutions. Usually stocks with elevated PS ratios are considered overvalued.

Standard BioTools has a net margin of -80.99% compared to Butterfly Network's net margin of -72.93%. Butterfly Network's return on equity of -37.41% beat Standard BioTools's return on equity of -36.54%.

Butterfly Network has a consensus price target of $5.00, signalling upside risk potential of 86.57%. On the other hand Standard BioTools has an analysts' consensus of $2.38 which suggests that it could grow by 108.33%. Given that Standard BioTools has higher upside potential than Butterfly Network, analysts believe Standard BioTools is more attractive than Butterfly Network.

Butterfly Network has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Standard BioTools has a beta of 1.621, suggesting its more volatile than the S&P 500 by 62.11%.

Butterfly Network has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Butterfly Network pays -- of its earnings as a dividend. Standard BioTools pays out -- of its earnings as a dividend.

Butterfly Network quarterly revenues are $22.4M, which are smaller than Standard BioTools quarterly revenues of $46.7M. Butterfly Network's net income of -$18.1M is higher than Standard BioTools's net income of -$34.1M. Notably, Butterfly Network's price-to-earnings ratio is -- while Standard BioTools's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Butterfly Network is 6.91x versus 2.31x for Standard BioTools. Usually stocks with elevated PS ratios are considered overvalued.

LENSAR has a net margin of -80.99% compared to Butterfly Network's net margin of -111.78%. Butterfly Network's return on equity of -37.41% beat LENSAR's return on equity of -134.77%.

Butterfly Network has a consensus price target of $5.00, signalling upside risk potential of 86.57%. On the other hand LENSAR has an analysts' consensus of $13.00 which suggests that it could grow by 2.45%. Given that Butterfly Network has higher upside potential than LENSAR, analysts believe Butterfly Network is more attractive than LENSAR.

Butterfly Network has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LENSAR has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Butterfly Network has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Butterfly Network pays -- of its earnings as a dividend. LENSAR pays out -- of its earnings as a dividend.

Butterfly Network quarterly revenues are $22.4M, which are larger than LENSAR quarterly revenues of $16.7M. Butterfly Network's net income of -$18.1M is higher than LENSAR's net income of -$18.7M. Notably, Butterfly Network's price-to-earnings ratio is -- while LENSAR's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Butterfly Network is 6.91x versus 3.26x for LENSAR. Usually stocks with elevated PS ratios are considered overvalued.

NeuroPace has a net margin of -80.99% compared to Butterfly Network's net margin of -24.46%. Butterfly Network's return on equity of -37.41% beat NeuroPace's return on equity of -216.38%.

Butterfly Network has a consensus price target of $5.00, signalling upside risk potential of 86.57%. On the other hand NeuroPace has an analysts' consensus of $17.57 which suggests that it could grow by 63.66%. Given that Butterfly Network has higher upside potential than NeuroPace, analysts believe Butterfly Network is more attractive than NeuroPace.

Butterfly Network has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NeuroPace has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Butterfly Network has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroPace offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Butterfly Network pays -- of its earnings as a dividend. NeuroPace pays out -- of its earnings as a dividend.

Butterfly Network quarterly revenues are $22.4M, which are larger than NeuroPace quarterly revenues of $21.5M. Butterfly Network's net income of -$18.1M is lower than NeuroPace's net income of -$5.3M. Notably, Butterfly Network's price-to-earnings ratio is -- while NeuroPace's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Butterfly Network is 6.91x versus 3.91x for NeuroPace. Usually stocks with elevated PS ratios are considered overvalued.